LLGLX Longleaf Partners Global Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN).

The investment seeks long-term capital growth. The Global Fund normally invests at least 40% of total assets in the equity securities of non-U.S. issuers throughout the world, which could include emerging market issuers, and may achieve its exposure to non-U.S. securities through investing in American depositary receipts (ADRs). The fund primarily owns common stock or securities convertible into common stocks. The fund is non-diversified.

The average market capitalization across the Longleaf Partners Global MF is 20.41B. The market cap for tickers in the group ranges from 159.25M to 80.75B. REGN holds the highest valuation in this group at 80.75B. The lowest valued company is CAN at 159.25M.

The average weekly volume growth across all stocks in the Longleaf Partners Global MF was -62%. For the same stocks of the MF, the average monthly volume growth was -57% and the average quarterly volume growth was -55%